跳至主要内容
临床试验/NCT06035796
NCT06035796尚未招募不适用

Performance Study of Targeted Sequencing Technology for Identification of Respiratory Pathogens and Drug Resistance Factor Analysis in VAP Patients

The First Hospital of Jilin University0 个研究点目标入组 150 人开始时间: 2023年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
150
主要终点
tNGS for pathogen detection rate and drug resistance rate in VAP

研究概览

简要总结

Main purpose: To evaluate the feasibility of tNGS for pathogen detection and drug resistance analysis in VAP patients.

Research site and research population:

This study is planned to be conducted in hospitals, targeting VAP patients. Perform clinical routine testing and tNGS testing on lower respiratory tract samples (BALF) from VAP patients, and collect patient clinical information. Clinical routine testing includes culture (necessary), microscopy, serology, PCR, etc., and drug sensitivity tests are conducted on positive culture samples as needed. Finally, compare the consistency of tNGS detection results with clinical culture, comprehensive diagnosis, and drug sensitivity results. Further validation was conducted on consistent negative or inconsistent samples through PCR and mNGS.

详细描述

The investigators plan to include 150 VAP patients in the ICU. Lower respiratory tract samples (BALF) from VAP patients were routinely tested and tNGS tested, and clinical information was collected. Routine clinical tests include culture (necessary), microscopic examination, serology, PCR, etc., and drug sensitivity tests are performed on positive culture samples as required. Finally, the consistency of tNGS test results with clinical culture, comprehensive diagnosis and drug sensitivity results was compared. The uniformly negative or inconsistent samples were further verified by PCR and mNGS.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • (1)VAP patients (2) Patients can collect the required test information

排除标准

  • (1) Clearly diagnosed as non-infectious patients
  • (2) Insufficient samples or patients unwilling to participate
  • (3) Life expectancy is less than 24 hours
  • (4) Patients' clinical information cannot be obtained

结局指标

主要结局

tNGS for pathogen detection rate and drug resistance rate in VAP

时间窗: 2years

Evaluating the feasibility of tNGS for pathogen detection rate and drug resistance rate in VAP patients

次要结局

  • Consistency rate of pathogen detection of tNGS with clinical practice(2 years)

研究者

申办方类型
Other
责任方
Sponsor

相似试验